HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Flynn Selected Research

molt-inhibiting hormone

1/2020Molecular cloning of crustacean hyperglycemic hormone (CHH) family members (CHH, molt-inhibiting hormone and mandibular organ-inhibiting hormone) and their expression levels in the Jonah crab, Cancer borealis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Flynn Research Topics

Disease

8Neoplasms (Cancer)
01/2020 - 04/2000
3Psoriasis (Pustulosis Palmaris et Plantaris)
04/2015 - 03/2011
3Autoimmune Diseases (Autoimmune Disease)
04/2013 - 03/2010
2Juvenile Arthritis (Juvenile Idiopathic Arthritis)
08/2014 - 03/2010
2Fibrosarcoma
04/2001 - 12/2000
2Carcinoma (Carcinomatosis)
02/2001 - 09/2000
1Hypotension (Low Blood Pressure)
06/2018
1Pain (Aches)
06/2018
1Rheumatoid Arthritis
04/2013
1Arthritis (Polyarthritis)
04/2012
1Synovitis
10/2010
1Ileus
02/2006
1Acute Kidney Injury (Acute Renal Failure)
02/2006
1Liposarcoma
07/2001
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2001
1Lewis Lung Carcinoma
04/2001
1Prostatic Neoplasms (Prostate Cancer)
02/2001
1Partial Epilepsies (Epilepsy, Partial)
01/2001
1Urinary Bladder Neoplasms (Bladder Cancer)
09/2000
1Transitional Cell Carcinoma
09/2000
1Hemangioma (Angioma)
04/2000
1Hemangiosarcoma (Angiosarcoma)
04/2000

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
10/2001 - 12/2000
2Hormones (Hormone)IBA
01/2020 - 02/2001
2Methotrexate (Mexate)FDA LinkGeneric
08/2014 - 04/2012
2Genetic Markers (Genetic Marker)IBA
04/2013 - 04/2012
2Interleukin-2 (IL2)IBA
03/2011 - 03/2010
2interleukin-21 (interleukin 21)IBA
03/2011 - 03/2010
2EndostatinsIBA
10/2001 - 04/2001
2EnzymesIBA
07/2001 - 12/2000
2AngiostatinsIBA
04/2001 - 03/2001
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2001 - 04/2000
2O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
03/2001 - 09/2000
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2001 - 04/2000
1Complementary DNA (cDNA)IBA
01/2020
1crustacean hyperglycemic hormoneIBA
01/2020
1molt-inhibiting hormoneIBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1Local AnestheticsIBA
06/2018
1Heroin (Diamorphine)IBA
06/2018
1Vasoconstrictor AgentsIBA
06/2018
1HLA-C Antigens (HLA-C)IBA
04/2015
1GoldIBA
03/2011
1IGF-I-IGFBP-3 complexFDA Link
03/2011
1CCR5 Receptors (CCR5 Receptor)IBA
10/2010
1CreatinineIBA
02/2006
1SuspensionsIBA
07/2001
1LigandsIBA
04/2001
1NeuropilinsIBA
04/2001
1Angiogenesis InhibitorsIBA
03/2001
1RNA (Ribonucleic Acid)IBA
02/2001
1AndrogensIBA
02/2001
1SteroidsIBA
02/2001
1Messenger RNA (mRNA)IBA
02/2001
1testis specific phosphoglycerate kinaseIBA
12/2000
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
12/2000
1Conditioned Culture MediaIBA
12/2000
1Phosphates (Orthophosphate)IBA
09/2000
1fumagillolIBA
09/2000
1Tumor Viral Antigens (Large T Antigen)IBA
04/2000
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2000
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2000
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2000

Therapy/Procedure

4Therapeutics
10/2001 - 09/2000
1Esophagectomy
06/2018
1Analgesia
06/2018
1Anesthesia
06/2018
1Catheters
06/2018
1Pain Management
06/2018
1Injections
04/2001
1Drug Therapy (Chemotherapy)
03/2001
1Castration
02/2001
1Electrodes (Electrode)
01/2001